Joseph Jackson

Has grant

Assistant Professor

University of Tennessee Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joseph Jackson is an Assistant Professor at The University of Tennessee Medical Center in the United States. His research encompasses oncolytic viral therapies, amyloid-related diseases, and the immune response in various conditions, as evidenced by his recent articles on glioblastoma treatment and cardiac amyloidosis detection. He focuses on innovative therapeutic solutions and the characterization of peptides and immunoglobulins in relation to amyloid pathology.

Recent Grants

Grant: Open

Addressing Collagen Mediated Protection of Systemic Amyloid Fibrils

Open Date: 2024-09-09

Close Date: 2028-08-31

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

University of Louisville School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joseph Jackson

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma

Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis

The Peptide Fusion Immunoglobulin, AT-02, Exhibits Highly Potent Pan-Amyloid Reactivity And Immunomodulation

Collagen inhibits phagocytosis of amyloid in vitro and in vivo and may act as a ‘don’t eat me’ signal

Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation

Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis

Oncolytic hsv vectors and anti-tumor immunity

Induction of neutrophil extracellular traps by Campylobacter jejuni.

Collaborators (6)

Jonathan S. Wall

Emily Martin

Jeremiah Johnson

William Goins

Trevor Hancock

Ryan Doster

Make your next move.